Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tauns LaboratoriesTSE:197A -0.82%14 Market Cap is 円51,524 Mil as of Jul. 18, 2026. GuruFocus rates TSE:197A with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Tauns Laboratories ranks better than 63.16% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tauns Laboratories's share price for the quarter that ended in Dec. 2025 was 円509. Tauns Laboratories's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 106 Mil. Therefore, Tauns Laboratories's market cap for the quarter that ended in Dec. 2025 was 円54,160 Mil.
Tauns Laboratories's quarterly market cap
increased
from Jun. 2025 (円55,410 Mil) to Sep. 2025 (円58,212 Mil) but then
declined
from Sep. 2025 (円58,212 Mil) to Dec. 2025 (円54,160 Mil).
Tauns Laboratories's annual market cap
increased
from Jun. 2023 (円0 Mil) to Jun. 2024 (円41,000 Mil) and
increased
from Jun. 2024 (円41,000 Mil) to Jun. 2025 (円55,410 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tauns Laboratories's Enterprise Value for Today is 円67,339 Mil.
Tauns Laboratories (TSE:197A) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Tauns Laboratories Market Cap Related Terms
Tauns Laboratories Market Cap Historical Data
* Premium members only.
The historical data trend for Tauns Laboratories's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:197A vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Tauns Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tauns Laboratories Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's Market Cap distribution charts can be found below:
* The bar in red indicates where Tauns Laboratories's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Tauns Laboratories's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tauns Laboratories (TSE:197A) has a Market Cap of 円51,524 Mil as of Jul. 18, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tauns Laboratories and its competitors. According to the industry distribution chart, Tauns Laboratories ranks #319 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 36.8%.
Is Tauns Laboratories' Market Cap too high?
Tauns Laboratories' current Market Cap is 円51,524 Mil. Based on the distribution chart, Tauns Laboratories ranks #319 out of 866 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tauns Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tauns Laboratories ranks #319 out of 866 companies for Market Cap. This puts Tauns Laboratories in the upper half of its industry. The industry median Market Cap is 115.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 115.63, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tauns Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 115.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tauns Laboratories's current Market Cap is 円51,524 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Market Cap of 円51,524 Mil. The current Market Cap is 円51,524 Mil. Tauns Laboratories' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Market Cap is 円51,524 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
14GF Score
Get the complete analysis for TSE:197A
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:197A has been successfully added to your 
